Free Trial
TSE:INO

Inovalis Real Estate Investment Trust (INO) Stock Price, News & Analysis

Inovalis Real Estate Investment Trust logo

About Inovalis Real Estate Investment Trust Stock (TSE:INO)

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA sequence of the target antigen, as well as CELLECTRA smart devices technology that facilitates delivery of the DNA plasmids. The company engages in conducting and planning clinical studies of its DNA medicines for HPV-associated precancers, including cervical, vulvar, and anal dysplasia; HPV-associated cancers, such as head and neck, cervical, anal, penile, vulvar, and vaginal; other HPV-associated disorders, including recurrent respiratory papillomatosis; glioblastoma multiforme; prostate cancer; HIV; Ebola; Middle East Respiratory Syndrome (MERS); and Lassa fever. Its partners and collaborators include ApolloBio Corp., AstraZeneca, Beijing Advaccine Biotechnology Co., Ltd., The Bill & Melinda Gates Foundation, Coalition for Epidemic Preparedness Innovations (CEPI), Defense Advanced Research Projects Agency (DARPA), Department of Defense (DoD), HIV Vaccines Trial Network, International Vaccine Institute, Kaneka Eurogentec, Medical CBRN Defense Consortium (MCDC), National Cancer Institute, National Institutes of Health, National Institute of Allergy and Infectious Diseases, Ology Bioservices, the Parker Institute for Cancer Immunotherapy, Plumbline Life Sciences, Regeneron Pharmaceuticals, Thermo Fisher Scientific, University of Pennsylvania, Walter Reed Army Institute of Research, and The Wistar Institute. The company has an agreement with Richter-Helm BioLogics GmbH & Co. KG to support investigational DNA vaccine INO-4800 for COVID-19; and a partnership with International Vaccine Institute and Seoul National University Hospital. The company was founded in 1979 and is headquartered in Plymouth Meeting, Pennsylvania.

Receive INO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Inovalis Real Estate Investment Trust and its competitors with MarketBeat's FREE daily newsletter.

INO Stock News Headlines

Why Buffett, Bezos, & Congress Are Piling Into This One Sector
Why are Warren Buffett, Jeff Bezos, Michael Bloomberg, “The Walmart Family”, Bill Gates, and 48 members of Congress shifting their stocks in a frenzy? And why are they all piling into ONE unique corner of the market…
See More Headlines

INO Stock Analysis - Frequently Asked Questions

Inovalis Real Estate Investment Trust (TSE:INO) posted its quarterly earnings data on Thursday, August, 8th. The company reported ($0.62) earnings per share for the quarter, missing analysts' consensus estimates of $0.02 by $0.64. The firm earned $4.62 million during the quarter.

Shares of INO stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that Inovalis Real Estate Investment Trust investors own include Artis REIT (AX), Walt Disney (DIS), Dynavax Technologies (DVAX), Harpoon Therapeutics (HARP), Moderna (MRNA), Pfizer (PFE) and TransAlta Renewables (RNW).

Company Calendar

Last Earnings
8/08/2024
Today
11/02/2024
Next Earnings (Estimated)
11/11/2024

Industry, Sector and Symbol

Industry
Surgical, Medical, And Dental Instruments And Supplies
Sub-Industry
Medical Equipment
CIK
N/A
Web
N/A
Fax
N/A
Employees
320
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
The Best High-Yield Dividend Stocks for 2024 Cover

Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.

Get This Free Report

This page (TSE:INO) was last updated on 11/2/2024 by MarketBeat.com Staff
From Our Partners